COMMUNIQUÉS West-GlobeNewswire

-
Unum Therapeutics to Host First Quarter 2019 Financial Results Conference Call and Webcast on May 13, 2019 at 8:00 A.M. ET
06/05/2019 -
Zynerba Pharmaceuticals Receives Fast Track Designation for Zygel™ for the Treatment of Behavioral Symptoms Associated with Fragile X Syndrome (FXS)
06/05/2019 -
Significant Clinical Progress as Adaptimmune Announces Responses with ADP-A2M4 in Synovial Sarcoma and Antitumor Activity in Other Solid Tumors
06/05/2019 -
Recro Pharma to Report First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 10, 2019
06/05/2019 -
One World Pharma Enters into First Colombian Seed Sale Agreement
06/05/2019 -
Axsome Therapeutics Announces Acceleration of MOMENTUM Phase 3 Trial of AXS-07 in Migraine
06/05/2019 -
Protalix BioTherapeutics Reports 2019 First Quarter Results and Provides Corporate Update
06/05/2019 -
Pluristem Files Patent Application for the Use of its Advanced Manufacturing Technology in the Cannabis Industry
06/05/2019 -
Arrayit Corporation Retains Top Credentialing Company to Accelerate Allergy Testing Services Reimbursement from Major Healthcare Payors
06/05/2019 -
Zealand Pharma hosts conference call on May 16 at 4 pm CET (10 am EST) to present first quarter results for 2019
06/05/2019 -
Share buy-back week 18/2019
06/05/2019 -
Ordinary and Extraordinary General Meeting of May 24, 2019 - Procedures for Obtaining Preparatory Documents for the General Meeting
06/05/2019 -
Assemblée Générale Mixte du 24 mai 2019 - Modalités de mise à disposition des documents préparatoires à l’Assemblée
06/05/2019 -
LIDDS: Liproca® Depot open label extension study indicates longer treatment intervals
06/05/2019 -
Reminder: C-RAD Web Presentation Interim Report Q1 2019
06/05/2019 -
Herantis Pharma publishes newsletter for March-April
06/05/2019 -
ERYTECH proposes the appointment of Dr. Jean-Paul Kress as Chairman of the Board of Directors
06/05/2019 -
ERYTECH propose la nomination du Dr. Jean-Paul Kress au poste de Président du Conseil d’administration
06/05/2019 -
Dr. Thomas Walters Presents Update on Nicox’s NCX 470 Phase 2 Clinical Study in Podium Presentation at ASCRS 2019
06/05/2019
Pages